At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
Straumann Bone Ceramic +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Controlled Clinical Study to Compare Bone Formation Around Micro-implants in the Maxilla After Sinus Floor Augmentation With Straumann Bone Ceramic or Bio-Oss in a Split Mouth Design
In Brief
A clinical study evaluating Straumann Bone Ceramic and BioOss for Jaw, Edentulous, Partially and Alveolar Bone Loss. Completed, enrolled 11 participants across 1 site.
Detailed Summary
Straumann Bone Ceramic (SBC) and BioOss will be used as bone grafting materials when there is a need for bone augmentation in the posterior upper jaw. 9 months later the bone formation is evaluated. The patients are followed for 3 years.The study hypothesis is that the SBC is not worse than BioOss.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsJaw, Edentulous, Partially, Alveolar Bone Loss
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2005
Primary CompletionJun 2007
Study CompletionDec 2008
First PostedMay 2009
TodayJul 2026
First PostedMay 13, 2009
Enrollment StartNov 1, 2005
Primary CompletionJun 1, 2007
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 17.1 years ago
Interventions
Straumann Bone Ceramicdevice
Granules applied once during surgery
BioOssdevice
Granules that are applied once during surgery